VIASURE Cystic Fibrosis NGS Solution

Amplification-based NGS kit for complete CFTR gene analysis to identify mutations responsible for cystic fibrosis. Enables comprehensive detection of genetic variants associated with this genetic disorder.

Next-generation sequencing testing kit for comprehensive genomic analysis and variant detection. Enables high-throughput sequencing for applications in molecular diagnostics and research.

NGS kit for amplification-based library preparation for complete analysis of the CFTR gene, whose mutations are responsible for Cystic Fibrosis. Provides targeted genetic screening for CF diagnosis.

High-sensitivity sequencing panels optimized for detecting even the lowest frequency genetic variants in patient samples. Designed for precise calling of single nucleotide variants, indels, and structural variations supporting confident diagnostic and monitoring applications.

A semi-automated kit for next-generation sequencing (NGS) of the exonic regions of the human genome, covering a 37.64 Mb region using genomic DNA extracted from whole blood and buccal swabs. The kit includes reagents for the preparation of DNA libraries enriched in exonic regions, intended for use on Illumina NGS sequencing platforms. It is designed for the identification of genetic variants in the exome to support the diagnosis of hereditary diseases, detect variants related to disease predisposition, and guide personalized medicine.

Next-generation sequencing diagnostic kits developed and manufactured for genomic analysis and sequencing applications. Provides complete kit solutions including reagents, components, and assembly with full GMP compliance.

Kit for preparation of next-generation sequencing libraries covering the entire human exome and mitochondrial genome. Designed for comprehensive genomic analysis applications requiring high-throughput sequencing capabilities.

iGenetech NGS kits enable next-generation sequencing for genomic analysis and molecular diagnostics. These kits support clinical applications including genetic testing, disease screening, and precision medicine workflows. Complete reagent systems designed for laboratory-based sequencing platforms.

NGS kits for next-generation sequencing-based molecular diagnostics of oncology, infectious disease, genetic disorders, and chronic conditions. Enables precision detection, disease diagnosis, pharmacogenomic profiling, and treatment monitoring across clinical and research settings.

PCR-based detection kit for identifying cystic fibrosis transmembrane conductance regulator mutations in patient samples. Enables genetic screening for cystic fibrosis susceptibility and diagnosis.

A clinically validated in vitro diagnostic NGS panel for tumor analysis and monitoring. Enables detection of low-frequency variants for precise patient monitoring and informed treatment decisions. Designed for confident calling of genomic alterations in oncology clinical practice.

Real-time PCR-based genetic test for detection of the deltaF508 mutation associated with cystic fibrosis. Enables rapid molecular diagnosis through cutting-edge genetic analysis technology. ISO 13485:2016 certified IVD product compliant with EU Regulation 2017/746.